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At the revision of the official dispensing fee in April 2010, a special fee was newly established for the cost of pharmaceutical 
management service for high-risk medicines (PMSHRM), and operational guidelines showing the standards for calculating the 
special fee were developed. No reports yet evaluate the usefulness of PMSHRM in accordance with these guidelines. Therefore, after 
conducting PMSHRM with simulated patients (SPs), we implemented a questionnaire survey for pharmacists and SPs to evaluate the 
usefulness of PMSHRM. According to the results, as compared with the conventional patient compliance instructions, 75.8% of those 
SPs who used the support sheets evaluated the PMSHRM highly. This result indicates the usefulness of PMSHRM. Moreover, 
approximately 80% of the responses indicated that SPs became more confident and more careful about their treatment when they felt 
their pharmacists were more reliable. The survey results suggested that treatment effects for patients would be enhanced by increasing 
their trust towards their pharmacists. 
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